6236 Stock Overview
Engages in the biotechnology, medical cosmetics, and preventive medicine businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Neith Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$30.20 |
| 52 Week High | NT$37.80 |
| 52 Week Low | NT$27.50 |
| Beta | 0.088 |
| 11 Month Change | -5.92% |
| 3 Month Change | -0.82% |
| 1 Year Change | 5.96% |
| 33 Year Change | 62.80% |
| 5 Year Change | 268.29% |
| Change since IPO | -89.85% |
Recent News & Updates
Shareholder Returns
| 6236 | TW Semiconductor | TW Market | |
|---|---|---|---|
| 7D | 2.7% | -1.5% | -0.5% |
| 1Y | 6.0% | 50.2% | 28.4% |
Return vs Industry: 6236 underperformed the TW Semiconductor industry which returned 51.7% over the past year.
Return vs Market: 6236 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 6236 volatility | |
|---|---|
| 6236 Average Weekly Movement | 5.8% |
| Semiconductor Industry Average Movement | 5.4% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.1% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6236 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6236's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Chun Wu | www.cometruebio.com |
Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; Max Care antrodia and turmeric capsules; and Max Care natto monascus capsules, as well as other nutritional products under the King One name. It also provides genetic testing services.
Neith Corporation Fundamentals Summary
| 6236 fundamental statistics | |
|---|---|
| Market cap | NT$1.26b |
| Earnings (TTM) | -NT$30.04m |
| Revenue (TTM) | NT$42.11m |
29.9x
P/S Ratio-41.9x
P/E RatioIs 6236 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6236 income statement (TTM) | |
|---|---|
| Revenue | NT$42.11m |
| Cost of Revenue | NT$15.11m |
| Gross Profit | NT$27.00m |
| Other Expenses | NT$57.04m |
| Earnings | -NT$30.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 64.12% |
| Net Profit Margin | -71.33% |
| Debt/Equity Ratio | 0% |
How did 6236 perform over the long term?
See historical performance and comparison